BRIEF-Bristol Myers Expects 2026 Adj EPS $6.05 To $6.35 vs IBES Estimate $6.02

Reuters
Feb 05
BRIEF-Bristol Myers Expects 2026 Adj EPS $6.05 To $6.35 vs IBES Estimate $6.02

Feb 5 (Reuters) - Bristol-Myers Squibb Co BMY.N:

  • BRISTOL MYERS Q4 ADJUSTED EPS INCLUDES NET IMPACT OF $-0.60 DUE TO ACQUIRED IPRD CHARGES & LICENSING INCOME

  • BRISTOL MYERS Q4 REVENUE $12.5 BILLION VERSUS IBES ESTIMATE $12.28 BILLION

  • BRISTOL MYERS OUTLOOK 2026 REVENUE ABOUT $46.0 BILLION TO $47.5 BILLION VERSUS IBES ESTIMATE $44.16 BILLION

  • BRISTOL MYERS Q4 ADJUSTED EPS $1.26 VERSUS IBES ESTIMATE $1.12

  • BRISTOL MYERS OUTLOOK 2026 ADJUSTED EPS $6.05 TO $6.35 VERSUS IBES ESTIMATE $6.02

  • BRISTOL MYERS OUTLOOK 2026 ELIQUIS WW REVENUE GROWTH 10% - 15%

Further company coverage: BMY.N

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10